4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-018328
Director bought 50,000 shares at an average $35.34 ($1,767,057)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamond David Director | 2021-03-04 | Purchase | +16,621 | $34.28 | $569,768 | 1,763,730 | I: show line 1 in the form |
| Lamond David Director | 2021-03-04 | Purchase | +13,310 | $35.00 | $465,850 | 1,777,040 | I: show line 2 in the form |
| Lamond David Director | 2021-03-04 | Purchase | +15,969 | $36.34 | $580,313 | 1,793,009 | I: show line 3 in the form |
| Lamond David Director | 2021-03-04 | Purchase | +4,100 | $36.86 | $151,126 | 1,797,109 | I: show line 4 in the form |
| Open-market purchases · 50,000 sh · avg $35.34 · $1,767,057 | |||||||
Loading xslF345X03/doc4.xml…